26Apr 2023
Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most?

Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: which comorbidities matter most?

This study examined the risk related to comorbidities, alone and in combination, both at individual and population levels. Using two clinical trials in HF, 14 133 (93.7%) had at least one and 11 867 (78.8%) had at least two of the 10 most common comorbidities. The greatest individual risk among pairs was associated with peripheral artery disease (PAD) in combination with stroke (hazard ratio [HR] 1.73; 95% confidence interval [CI] 1.28–2.33) and anaemia (HR 1.71; 95% CI 1.39–2.11). The combination of chronic kidney disease (CKD) and hypertension had the highest PAF (5.65%; 95% CI 3.66–7.61). Two pairs demonstrated significant synergistic interaction (atrial fibrillation with CKD and coronary artery disease) and one an antagonistic interaction (anaemia and obesity). In HF, the impact of multimorbidity differed at the individual patient and population level, depending on the prevalence of and the risk related to each comorbidity, and the interaction between individual comorbidities.

  • #cardiology

Like

Save

Share